Fig. 4: Estimated symptomatic COVID-19 cases and deaths under different vaccination coverage scenarios. | npj Vaccines

Fig. 4: Estimated symptomatic COVID-19 cases and deaths under different vaccination coverage scenarios.

From: A Bayesian network analysis quantifying risks versus benefits of the Pfizer COVID-19 vaccine in Australia

Fig. 4

Comparison of expected number of COVID-19 cases (a) and deaths (b) per million population by age groups under vaccine coverage scenario one (5% of population of ages ≥12 years had no doses, 5% had first dose, 60% had two doses [evenly distributed across time since second dose], and 30% had three doses of Pfizer COVID-19 vaccine), versus coverage scenario two (0% of population had no doses, 5% had one dose, 15% had two doses [evenly distributed across times since second dose] and 80% had three doses), under a transmission scenario equivalent to 10% chance of infection over 2 months.

Back to article page